Udiliv Tablet 1*15

1. **Treatment of Cholestatic Liver Diseases**: Udiliv is primarily used in the treatment of cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). These are conditions where the flow of bile from the liver is impaired, leading to bile accumulation and liver damage.

2. **Promotes Bile Flow**: UDCA helps to improve bile flow from the liver and reduces the concentration of toxic bile acids in the liver, which can help alleviate symptoms and slow the progression of liver damage in cholestatic liver diseases.

3. **Reduces Liver Enzymes**: UDCA has been shown to reduce elevated levels of liver enzymes, such as alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT), which are markers of liver injury in cholestatic liver diseases.

4. **Prevents Gallstone Formation**: Udiliv can also be used to prevent the formation of cholesterol gallstones in individuals who are at risk of developing them, such as those who have undergone rapid weight loss or certain types of bariatric surgery.

5. **Improves Liver Function Tests**: Treatment with Udiliv may lead to improvements in liver function tests and overall liver function in patients with cholestatic liver diseases.

6. **Symptom Relief**: Udiliv may help relieve symptoms associated with cholestatic liver diseases, such as fatigue, pruritus (itching), jaundice, and abdominal discomfort.

7. **Safety and Tolerability**: UDCA is generally well tolerated with few side effects, making it suitable for long-term use in the management of chronic liver diseases.

It’s important to note that Udiliv tablets should only be used under the supervision of a healthcare professional, and the dosage and duration of treatment will depend on the specific condition being treated and individual patient factors.